Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

MoonLake regains momentum after the FDA Type B meeting allows BLA submission for sonelokimab in HS without additional trials.

Plenty of people – about 1 in 3, according to some studies — feel bad for a day or two after they get a flu shot. The most common symptoms include headaches, muscle aches, fatigue and fever, all of ...

FDA oral Wegovy, solid fundamentals, and low P/E vs. Eli Lilly. Click for this updated look at NVO stock prospects as ...

ABCmouse, the award-winning early learning platform trusted by families and educators for more than 15 years, today launched an all-new version of its program?completely reimagined to bring the magic ...

SAN FRANCISCO -- Incorporating the recently approved bispecific antibody zanidatamab (Ziihera) into first-line treatment for ...

With durable responses, encouraging survival outcomes, and evidence that some patients may become eligible for ...

Detailed price information for Allogene Therapeutics Inc (ALLO-Q) from The Globe and Mail including charting and trades.

Not all cognitive supplements are created equal. While the term “nootropic” is often used broadly, the supplements gaining the most traction typically share a common trait: they are being studied, ...